Cerebrospinal fluid somatostatin in delirium

Area of Science:

• Neuroscience
• Geriatrics
• Biochemistry

Background:

• Delirium is a common neuropsychiatric syndrome in the elderly.
• Cerebrospinal fluid somatostatin-like immunoreactivity (CSF SLI) has been implicated in cognitive function.
• Previous studies suggest reduced CSF SLI in conditions with cognitive impairment.

Purpose of the Study:

• To investigate CSF SLI levels in elderly patients diagnosed with delirium.
• To determine the relationship between CSF SLI and cognitive decline in delirium.
• To explore potential correlations with central nervous system disease types.

Main Methods:

• Measurement of CSF SLI in 67 elderly patients meeting DSM-III criteria for delirium.
• Comparison with 19 age-matched healthy controls.
• Subgroup analysis based on delirium type, cognitive severity, and CNS disease.

Main Results:

• Delirious patients exhibited significantly lower CSF SLI compared to controls.
• A trend of decreasing CSF SLI was observed with increasing cognitive dysfunction.
• Reductions in CSF SLI were consistent across different delirium subtypes and CNS diseases.

Conclusions:

• Reduced CSF SLI is a characteristic finding in elderly patients with delirium.
• CSF SLI may serve as a biomarker for cognitive dysfunction in delirium.
• These findings support the role of somatostatin in the pathophysiology of delirium.